Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC). A study of the National Cancer Institute of Canada Clinical Trials Group (Q72426675)
Jump to navigation
Jump to search
scientific article published on 01 March 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC). A study of the National Cancer Institute of Canada Clinical Trials Group |
scientific article published on 01 March 1994 |
Statements
Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC). A study of the National Cancer Institute of Canada Clinical Trials Group (English)
Y Cormier
E Eisenhauer
A Muldal
R Gregg
J Ayoub
G Goss
D Stewart
P Tarasoff